ANTONELLA CUSIMANO
- Type
- Persona (Classe)
- Label
- ANTONELLA CUSIMANO (literal)
- ANTONELLA CUSIMANO (literal)
- Http://www.w3.org/2002/07/owl#sameAs
- ANTONELLA CUSIMANO (Persona)
- Persona in rapporto
- Rapporto con CNR di DOTT.SSA ANTONELLA CUSIMANO (Rapporto con CNR)
- Autore CNR di
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) (Articolo in rivista) (Prodotto della ricerca)
- Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Episodic Ataxia Type 1 mutation F184C alters Zn2+-induced modulation of the human potassium channel Kv1.4-Kv1.1/Kv{beta}1.1. (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Molecular mechanisms of sorafenib action in liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenases in cancer (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- A general path for large-scale solubilization of cellular proteins: From membrane receptors to multiprotein complexes. (Articolo in rivista) (Prodotto della ricerca)
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. (Articolo in rivista) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (Prodotto della ricerca)
- An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ (Articolo in rivista) (Prodotto della ricerca)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (Prodotto della ricerca)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Coautore
- ANTONINA AZZOLINA (Unità di personale interno)
- GIOVANNI PERCONTI (Unità di personale esterno)
- MELCHIORRE CERVELLO (Persona)
- AGATA GIALLONGO (Unità di personale interno)
- VERONICA POMA (Unità di personale esterno)
- Giuseppe Montalto (Unità di personale esterno)
- NATALE D'ALESSANDRO (Unità di personale esterno)
- Lydia Giannitrapani (Unità di personale esterno)
- PATRIZIA RUBINO (Persona)
- NADIA LAMPIASI (Persona)
- Nome
- ANTONELLA (literal)
- Cognome
- CUSIMANO (literal)
- Afferisce a
- Ha pubblicazioni con
- PATRIZIA RUBINO (Persona)
- NATALE D'ALESSANDRO (Unità di personale esterno)
- Giuseppe Montalto (Unità di personale esterno)
- NADIA LAMPIASI (Persona)
- MELCHIORRE CERVELLO (Persona)
- AGATA GIALLONGO (Unità di personale interno)
- Lydia Giannitrapani (Unità di personale esterno)
- VERONICA POMA (Unità di personale esterno)
- ANTONINA AZZOLINA (Unità di personale interno)
Incoming links:
- Autore CNR
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (Prodotto della ricerca)
- Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) (Articolo in rivista) (Prodotto della ricerca)
- Episodic Ataxia Type 1 mutation F184C alters Zn2+-induced modulation of the human potassium channel Kv1.4-Kv1.1/Kv{beta}1.1. (Articolo in rivista) (Prodotto della ricerca)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Cyclooxygenases in cancer (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Molecular mechanisms of sorafenib action in liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. (Articolo in rivista) (Prodotto della ricerca)
- A general path for large-scale solubilization of cellular proteins: From membrane receptors to multiprotein complexes. (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- MELCHIORRE CERVELLO (Persona)
- AGATA GIALLONGO (Unità di personale interno)
- PATRIZIA RUBINO (Persona)
- NADIA LAMPIASI (Persona)
- ANTONINA AZZOLINA (Unità di personale interno)
- NATALE D'ALESSANDRO (Unità di personale esterno)
- Giuseppe Montalto (Unità di personale esterno)
- VERONICA POMA (Unità di personale esterno)
- GIOVANNI PERCONTI (Unità di personale esterno)
- Lydia Giannitrapani (Unità di personale esterno)
- Ha pubblicazioni con
- MELCHIORRE CERVELLO (Persona)
- AGATA GIALLONGO (Unità di personale interno)
- PATRIZIA RUBINO (Persona)
- NADIA LAMPIASI (Persona)
- ANTONINA AZZOLINA (Unità di personale interno)
- NATALE D'ALESSANDRO (Unità di personale esterno)
- Giuseppe Montalto (Unità di personale esterno)
- VERONICA POMA (Unità di personale esterno)
- Lydia Giannitrapani (Unità di personale esterno)
- Ha afferente
- Rapporto con persona
- Rapporto con CNR di DOTT.SSA ANTONELLA CUSIMANO (Rapporto con CNR)